Abstract
Croup, or laryngotracheobronchitis, is a common childhood illness most often caused by viral infections. It is usually a benign, self-limiting disease, but can result in life-threatening upper airway obstruction. Until recently, it was not uncommon for children with severe croup to be admitted to intensive care for intubation. Management used to be limited to supportive measures, including mist therapy. The use of corticosteroids in patients with croup was controversial for many years but has, in the last decade, transformed the management of this disorder. Although corticosteroids do not alter the history of the viral infection, an adequate dose of oral or parenteral dexamethasone or nebulized budesonide has been shown to have a beneficial effect on the symptoms of croup.
Similar content being viewed by others
References
Denny FW, Murphy TF, Clyde WA, et al. Croup: an 11-year study in a pediatric practice. Pediatrics 1983; 71(6): 871–6
Skolnik N. Croup. J Fam Pract 1993; 37(2): 165–70
Rosekrans JA. Viral croup: current diagnosis and treatment. Mayo Clin Proc 1998; 73(11): 1102–6
Henrickson KJ, Kuhn SM, Savatski LL. Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis 1994; 18: 770–9
Macdonald WBG, Geelhoed GC. Management of childhood croup. Thorax 1997; 52(9): 757–9
Geelhoed GC. Croup. Pediatr Pulmonol 1997; 23(5): 370–4
Phelan PD, Landau LI, Olinsky A. Respiratory illness in children. 3rd ed. Oxford: Blackwell Scientific Publications, 1990
Zach M, Erben A, Olinsky A. Croup, recurrent croup, allergy and airways hyper-reactivity. Arch Dis Child 1981; 56(5): 336–41
Zach MS, Schnall RP, Landau LI. Upper and lower airway hyperreactivity in recurrent croup. Am Rev Respir Dis 1980; 121: 979–83
Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. Am J Dis Child 1978; 132: 484–7
Klassen TP, Rowe PC. The croup score as an evaluative instrument in clinical trials [abstract]. Arch Pediatr Adolesc Med 1995; 149: 60
Corticosteroids for croup. Drug Ther Bull 2000; 38(3): 22–4
Ausejo M, Saenz A, Pham B, et al. The effectiveness of glucocorticoids in treating croup: meta-analysis. BMJ 1999; 319: 595–600
Steele DW, Santucci KA, Wright RO, et al. Pulsus paradoxus: an objective measure of severity of croup. Am J Respir Crit Care Med 1997; 156: 331–4
Rittichier KK, Ledwith CA. Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics 2000; 106(6): 1344–8
Henry R. Moist air in the treatment of laryngotracheitis [letter]. Arch Dis Child 1983; 58: 577
Bourchier D, Dawson KP, Fergusson DM. Humidification in viral croup: a controlled trial. Aust Paediatr J 1984; 20: 289–91
Geelhoed GC. Sixteen years of croup in a Western Australian teaching hospital: effects of routine steroid treatment. Ann Emerg Med 1996; 28(6): 621–6
Greally P, Cheng K, Tanner MS, et al. Children with croup presenting with scalds [case reports]. BMJ 1990; 301: 113
Orlicek SL. Management of acute laryngotracheo-bronchitis. Pediatr Infect Dis J 1998; 17(12): 1164–5
Klassen TP. Croup: a current perspective. Pediatr Clin North Am 1999; 46(6): 1167–78
Taussig LM, Castro O, Beaudry PH, et al. Treatment of laryngotracheobronchitis (croup): use of intermittent positive-pressure breathing and racemic epinephrine. Am J Dis Child 1975; 129: 790–3
Fogel JM, Berg IJ, Gerber MA, et al. Racemic epinephrine in the treatment of croup: nebulization alone versus nebulization with intermittent positive pressure breathing. J Pediatr 1982; 101(6): 1028–31
Gardner HG, Powell KR, Roden VJ, et al. The evaluation of racemic epinephrine in the treatment of infectious croup. Pediatrics 1973; 52(1): 52–5
Innes Asher M. Infections of the upper respiratory tract. In: Taussig LM, Landau LI, editors. Pediatric Respiratory Medicine. St Louis (MO): Mosby, 1999: 541
Rizos JD, DiGravio BE, Sehl MJ, et al. The disposition of children with croup treated with racemic epinephrine and dexamethasone in the emergency department. J Emerg Med 1998; 16(4): 535–9
Kunkel NC, Baker MD. Use of racemic epinephrine, dexamethasone, and mist in the outpatient management of croup. Pediatr Emerg Care 1996; 12(3): 156–9
Ledwith CA, Shea LM, Mauro RD. Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup. Ann Emerg Med 1995; 25(3): 331–7
Prendergast M, Jones JS, Hartman D. Racemic epinephrine in the treatment of laryngotracheitis: can we identify children for outpatient therapy? Am J Emerg Med 1994; 12(6): 613–6
Kelley PB, Simon JE. Racemic epinephrine use in croup and disposition. Am J Emerg Med 1992; 10: 181–3
Kuusela AL, Vesikari T. A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatr Scand 1988; 77: 99–104
Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic aerosols in the treatment of laryngotracheitis (croup). Pediatrics 1992; 89(2): 302–6
Nutman J, Brooks LJ, Deakins KM, et al. Racemic versus L-epinephrine aerosol in the treatment of postextubation laryngeal edema: results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22(10): 1591–4
Ross JAT. Special problems in acute laryngotracheobronchitis. Laryngoscope 1969; 79: 1218–26
Johnson DW, Jacobson S, Edney PC, et al. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med 1998 Aug; 339(8): 498–503
Tunnessen Jr WW, Feinstein AR. The steroid-croup controversy: an analytic review of methodological problems. J Pediatr 1980; 96(4): 751–6
Novik A. Corticosteroid treatment of non-diphtheritic croup. Acta Otolaryngol 1960; 158 Suppl.: 20–2
Martensson B, Nilson G, Torbjar J. The effect of corticosteroids in the treatment of pseudo-croup. Acta Otolaryngol 1960; 158 Suppl.: 62–71
James JA. Dexamethasone in croup: a controlled study. Am J Dis Child 1969; 117: 511–6
Leipzig B, Oski FA, Cummings CW, et al. A prospective randomised study to determine the efficacy of steroids in treatment of croup. J Pediatr 1979; 94: 194–6
Eden A, Larkin VP. Corticosteroid treatment of croup. Pediatrics 1964; 33: 768–9
Eden A, Kaufman A, Yu R. Corticosteroid and croup. JAMA 1967; 200(5): 403–4
Sussman S, Grossman M, Magoffin R, et al. Dexamethasone (16 alpha-methyl, 9 alpha-fluoroprednisolone) in obstructive respiratory tract infections in children. Pediatrics 1964; 34: 851–5
Skowron PN, Turner JAP, McNaughton GA. The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Can Med Assoc J 1966; 94: 528–31
Landau LI, Geelhoed GC. Aerosolized steroids for croup. N Engl J Med 1994; 331(5): 322–3
Kairys SW, Olmstead EM, O’Connor GT. Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials. Pediatrics 1989; 83: 683–93
von Muhlendahl KE, Kahn D, Spohr HL, et al. Steroid treatment of pseudo-croup. Helv Paediatr Acta 1982; 37: 431–6
Koren G, Frand M, Barzilay Z, et al. Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. Am J Dis Child 1983; 137: 941–4
Tibballs J, Shann FA, Landau LI. Placebo-controlled trial of prednisolone in children intubated for croup. Lancet 1992; 340: 745–8
Roorda RJ, Walhof CM. Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatr Pulmonol 1998; 25: 114–7
Super DM, Cartelli NA, Brooks LJ, et al. A prospective randomized double-blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. J Pediatr 1989; 115: 323–9
Geelhoed GC, Macdonald WBG. Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatr Pulmonol 1995; 20: 362–8
Geelhoed GC, Turner J, Macdonald WBG. Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ 1996; 313: 140–2
Cruz MN, Stewart G, Rosenberg N. Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics 1995; 96(2): 220–3
Geelhoed GC, Macdonald WBG. Oral and inhaled steroids in croup: a randomized, placebo-controlled trial. Pediatr Pulmonol 1995; 20: 355–61
Husby S, Agertoft L, Mortensen S, et al. Treatment of croup with nebulised steroids (budesonide): a double blind, placebo controlled study. Arch Dis Child 1993; 68: 352–5
Godden CW, Campbell MJ, Hussey M, et al. Double blind, placebo controlled trial of nebulised budesonide for croup. Arch Dis Child 1997; 76(2): 155–7
Klassen TP, Feldman ME, Watters LK, et al. Nebulized budesonide for children with mild-to-moderate croup. N Engl J Med 1994; 331(5): 285–9
Roberts GW, Master VV, Staugas RE, et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. J Paediatr Child Health 1999; 35: 170–4
Klassen TP, Watters LK, Feldman ME, et al. The efficacy of nebulized budesonide in dexamethasone-treated outpatients with croup. Pediatrics 1996; 97(4): 463–6
Klassen TP, Craig WR, Moher D, et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA 1998; 279(20): 1629–32
Jothimurugan S, Zoaka H, Silverman M. Effectiveness of glucocorticoids in treating croup: children with croup should receive corticosteroids in primary care: results of audit [letter]. BMJ 1999; 319(7224): 1577
Tillett AJ, Gould JDM. Effectiveness of glucocorticoids in treating croup: general practitioners must be ready to treat children [letter]. BMJ 1999; 319(7724): 1577
Johnson DW, Schuh S, Koren G, et al. Outpatient treatment of croup with nebulized dexamethasone. Arch Pediatr Adolesc Med 1996; 150(4): 349–55
Kiff KM, Mok Q, Dunne J, et al. Steroids for intubated croup masking airway haemangioma. Arch Dis Child 1996; 74(1): 66–7
Acknowledgements
Dr Wendy Stannard is supported by the Cystic Fibrosis Trust.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stannard, W., O’Callaghan, C. Management of Croup. Pediatr-Drugs 4, 231–240 (2002). https://doi.org/10.2165/00128072-200204040-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128072-200204040-00003